Webinar

How early-phase modeling provides better, faster pricing and development strategies

  • PharmaLex, a Cencora company

Summer Shorts Webinar Series
Early-phase modeling (EPM) offers valuable insights and guidance on critical factors influencing pricing potential for products much earlier in the development cycle than traditional methods.

Key insights

Learn from our speakers to explore how advanced visibility into product costs and effectiveness can significantly benefit organizations in several key areas. This approach facilitates the development of pricing and reimbursement strategies, assesses the impact of various outcomes from planned or ongoing clinical studies, and helps identify data gaps in clinical trials. Additionally, it allows organizations to explore value before clinical trial data is available, guiding decisions regarding further research and development. We'll also cover how to identify potential challenges in early-stage development and determine the relative importance of different parameters. Chris Englerth, our Director of Global Consulting Services, moderated this session alongside Annabelle Forsmark, our Associate Director of Market Access and Healthcare Consulting.

Summer Shorts

Access the recording

Pardot Form

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.

Related resources

Article

Harmonizing Health Technology Assessment: PICO consolidation under the EU HTA Regulation
Learn more

Article

Insights for innovation: AMCP Nexus 2025 educational videos
Learn more

Article

HTA Quarterly Winter 2025 Summary
Learn more

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.